New painkiller may reduce nausea after hysterectomy
NCT ID NCT07326683
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new painkiller called tegileridine against the standard drug oxycodone in 68 women recovering from laparoscopic hysterectomy. The main goal was to see which drug caused less nausea and vomiting after surgery. Both drugs were given through an IV, and patients could get extra pain relief if needed. The results could help doctors choose a better option for postoperative pain control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tegileridine (a new painkiller) and oxycodone (a standard painkiller)
- What this could lead to
- If tegileridine works better with fewer side effects like nausea, it could offer a new option for managing pain after surgery.
- What could go wrong
- This is a small, single-center study with only 68 participants. The results may not apply to everyone, and tegileridine is still new with unknown long-term risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL LAPAROSCOPIC HYSTERECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anesthesiology,the Second Affiliated Hospital of Hainan Medical University
Haikou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.